Ren-Hua Fan1, Jing Li, Nan Wu, Ping-Sheng Chen. 1. Department of Pathology, School of Medicine, Southeast University, Nanjing 210009, Jiangsu Province, China.
Abstract
AIM: To investigate the relationship between late SV40 factor (LSF) and Notch signaling in the development and progress of hepatocellular carcinoma (HCC). METHODS: Liver cancer tissue specimens from 25 patients were analyzed for Notch-1 and LSF expression by immunohistochemistry. The correlation between expression and the biological effects of Notch-1 and LSF were analyzed using genetic and pharmacological strategies in HCC cell lines and human normal cell lines, including hepatic stellate cells (HSC) and human embryonic kidney epithelial cells (HEK). RESULTS: Immunohistochemistry showed that both Notch-1 and LSF were significantly upregulated in HCC samples (76%, 19/25, P < 0.0001 and 84%, 21/25, P < 0.0001, respectively) compared with non-cancer samples. Activation of Notch-1 by exogenous transfection of Notch1 intracellular domain increased LSF expression in HSC and HEK cells to levels similar to those seen in HepG2 cells. Furthermore, blocking Notch-1 activation with a γ-secretase inhibitor, DAPT, downregulated LSF expression in HepG2 cells. Additionally, a biological behavior assay showed that forced overexpression of LSF promoted HepG2 cell proliferation and invasion. CONCLUSION: LSF is a key mediator of the Notch signaling pathway, suggesting that it might be a novel therapeutic target for the treatment of HCC.
AIM: To investigate the relationship between late SV40 factor (LSF) and Notch signaling in the development and progress of hepatocellular carcinoma (HCC). METHODS:Liver cancer tissue specimens from 25 patients were analyzed for Notch-1 and LSF expression by immunohistochemistry. The correlation between expression and the biological effects of Notch-1 and LSF were analyzed using genetic and pharmacological strategies in HCC cell lines and human normal cell lines, including hepatic stellate cells (HSC) and humanembryonic kidney epithelial cells (HEK). RESULTS: Immunohistochemistry showed that both Notch-1 and LSF were significantly upregulated in HCC samples (76%, 19/25, P < 0.0001 and 84%, 21/25, P < 0.0001, respectively) compared with non-cancer samples. Activation of Notch-1 by exogenous transfection of Notch1 intracellular domain increased LSF expression in HSC and HEK cells to levels similar to those seen in HepG2 cells. Furthermore, blocking Notch-1 activation with a γ-secretase inhibitor, DAPT, downregulated LSF expression in HepG2 cells. Additionally, a biological behavior assay showed that forced overexpression of LSF promoted HepG2 cell proliferation and invasion. CONCLUSION:LSF is a key mediator of the Notch signaling pathway, suggesting that it might be a novel therapeutic target for the treatment of HCC.
Entities:
Keywords:
Hepatocellular carcinoma; Late SV40 factor; Notch receptor; Signal transduction
Authors: Peter Ferenci; Michael Fried; Douglas Labrecque; J Bruix; M Sherman; M Omata; J Heathcote; T Piratsivuth; Mike Kew; Jesse A Otegbayo; S S Zheng; S Sarin; S Hamid; Salma Barakat Modawi; Wolfgang Fleig; Suliman Fedail; Alan Thomson; Aamir Khan; Peter Malfertheiner; George Lau; F J Carillo; Justus Krabshuis; Anton Le Mair Journal: J Gastrointestin Liver Dis Date: 2010-09 Impact factor: 2.008
Authors: Franziska Jundt; Ioannis Anagnostopoulos; Reinhold Förster; Stephan Mathas; Harald Stein; Bernd Dörken Journal: Blood Date: 2002-05-01 Impact factor: 22.113
Authors: Britta Westhoff; Ivan N Colaluca; Giovanni D'Ario; Maddalena Donzelli; Daniela Tosoni; Sara Volorio; Giuseppe Pelosi; Lorenzo Spaggiari; Giovanni Mazzarol; Giuseppe Viale; Salvatore Pece; Pier Paolo Di Fiore Journal: Proc Natl Acad Sci U S A Date: 2009-12-10 Impact factor: 11.205
Authors: Sanne Weijzen; Paola Rizzo; Mike Braid; Radhika Vaishnav; Suzanne M Jonkheer; Andrei Zlobin; Barbara A Osborne; Sridevi Gottipati; Jon C Aster; William C Hahn; Michael Rudolf; Kalliopi Siziopikou; W Martin Kast; Lucio Miele Journal: Nat Med Date: 2002-08-19 Impact factor: 53.440
Authors: Prasanna K Santhekadur; Devaraja Rajasekaran; Ayesha Siddiq; Rachel Gredler; Dong Chen; Scott E Schaus; Ulla Hansen; Paul B Fisher; Devanand Sarkar Journal: Am J Cancer Res Date: 2012-04-21 Impact factor: 6.166
Authors: Trevor J Grant; Joshua A Bishop; Lisa M Christadore; Girish Barot; Hang Gyeong Chin; Sarah Woodson; John Kavouris; Ayesha Siddiq; Rachel Gredler; Xue-Ning Shen; Jennifer Sherman; Tracy Meehan; Kevin Fitzgerald; Sriharsa Pradhan; Laura A Briggs; William H Andrews; Devanand Sarkar; Scott E Schaus; Ulla Hansen Journal: Proc Natl Acad Sci U S A Date: 2012-03-06 Impact factor: 11.205
Authors: Devaraja Rajasekaran; Ayesha Siddiq; Jennifer L S Willoughby; Jessica M Biagi; Lisa M Christadore; Sarah A Yunes; Rachel Gredler; Nidhi Jariwala; Chadia L Robertson; Maaged A Akiel; Xue-Ning Shen; Mark A Subler; Jolene J Windle; Scott E Schaus; Paul B Fisher; Ulla Hansen; Devanand Sarkar Journal: Oncotarget Date: 2015-09-22